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Abstract 
 
Background: MacIver and Townsend’s hypothesis predicts, based on a mathematical model 
of left ventricular (LV) contraction, that preserved absolute radial wall thickening (radWT) 
due to LV hypertrophy is responsible for the normal ejection fraction (EF) in patients with 
heart failure with preserved ejection fraction (HFPEF).  Methods: We tested the validity of 
this hypothesis by detailed echocardiography including evaluation of ventricular myocardial 
strain (S) using speckle tracking imaging in >60-year-old 18 controls and 94 hypertensive 
patients with normal EF.  Results: Echocardiography revealed no LV diastolic dysfunction in 
38/94(40%) patients with HT (HTDD- group), and 56/94(60%) patients had diastolic 
dysfunction (HTDD+ group).  The absolute values of global longitudinal LV peak systolic S 
were significantly reduced in both patient groups (p<0.05 for HTDD-, p<0.01 for HTDD+ 
groups) versus the controls.  There were no significant between-groups differences in 
circumferential and radial peak LV systolic Ss, radWT and EF.  LV mass (LVM) (p<0.001), 
LVM/body mass index (BMI) (p<0.01) increased in the HTDD+ group and EF/LVM/BMI 
decreased in both patient groups (p<0.01 for HTDD-, p<0.001 for HTDD+ groups) versus the 
controls.  LVM increased, EF/LVM/BMI decreased in the HTDD+ group versus the HTDD- 
group (p<0.05 and p<0.01 respectively).  Conclusions: We demonstrated decreased 
longitudinal LV systolic function, and showed that preserved EF was due to preserved 
absolute radWT and not to increased radial or circumferential systolic function in patients 
with HT and normal EF, a potential HFPEF precursor condition. Instead of EF, rather 
EF/LVM/BMI might be used to detect subtle LV systolic dysfunction in hypertension and 
HFPEF. 
Key words: heart failure with preserved ejection fraction, hypertension, left ventricular 
function 
3 
 
 
Condensed abstract 
 
MacIver and Townsend’s hypothesis predicts that preserved absolute radial wall thickening 
(radWT) due to left ventricular (LV) hypertrophy is responsible for the normal ejection 
fraction (EF) in heart failure patients with preserved ejection fraction (HFPEF).  Detailed 
echocardiography was performed in >60-year-old normotensive and hypertensive patients 
with normal EF and with or without LV diastolic dysfunction.  Global longitudinal LV peak 
systolic strain in both hypertensive groups was reduced versus the normotensive group but 
circumferential and radial peak LV systolic strains, radWT and EF did not change.  In 
conclusion, we verified the validity of MacIver and Townsend’s hypothesis demonstrating 
that normal EF was due to preserved absolute radWT and not to increased radial or 
circumferential systolic function in hypertensive patients with normal EF, a precursor 
condition of HFPEF. 
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Abbreviations 
 
A’=mitral annulus peak late diastolic velocity 
BMI=body mass index 
BSA=body surface area 
DT=deceleration time 
E’=mitral annulus peak early diastolic filling velocity  
EDV=end-diastolic volume 
EF=ejection fraction 
EF(S)=EF Simpson 
ESV=end-systolic volume 
GLS=global longitudinal left ventricular peak systolic strain 
HFPEF=heart failure with preserved ejection fraction 
IVA=isovolumic acceleration 
IVRT=isovolumic relaxation time 
IVV=isovolumic velocity 
LA=left atrial 
LAV=left atrial volume 
LV=left ventricular 
LVH=left ventricular hypertrophy 
LVM=left ventricular mass 
LVOT-TVI=left ventricular outflow tract time velocity integral 
radWT=radial wall thickening 
S=strain 
SV=stroke volume 
STI=speckle tracking imaging 
TDI=tissue Doppler imaging 
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Introduction 
 
Reduced left ventricular (LV) systolic function despite normal LV ejection fraction 
(LVEF) was reported in heart failure with preserved ejection fraction (HFPEF)
1-3
 or in 
hypertension with normal EF
4-6
, which is a precursor state of HFPEF. 
Controversy exists concerning the mechanism of normal EF in HFPEF.  Although 
decreased longitudinal LV systolic strain (S) was repeatedly demonstrated
2-6
, there are 
conflicting reports about radial and circumferential S in HFPEF and in hypertension with 
normal EF.  Some authors reported that reduced longitudinal LV systolic S and yet normal 
LVEF in HFPEF is due to a compensatory increase in circumferential and/or radial 
function
1,7-9
.  Radial S was increased in asymptomatic mildly hypertensive patients, however, 
radial S decreased as symptoms appeared, LV hypertrophy (LVH) progressed, and the 
severity of heart failure increased.
10,11 
  In more advanced disease with concentric LVH and a 
normal EF the longitudinal S was reduced besides decreased circumferential and radial S.
12
  
MacIver and Townsend
13
 suggested that the concept of commonly present diastolic 
dysfunction is unnecessary to describe the pathophysiology of HFPEF.  LV thickening 
depends on both myocardial shortening and end-diastolic wall thickness.  Because the 
myocardium is non-compressible, longitudinal and circumferential shortening results in radial 
thickening.  Thus, reduced long-axis and circumferential shortening should reduce radial 
thickening (strain).
14
  Since LVH is present in HFPEF, the paradox of reduced longitudinal, 
circumferential and radial S yet a normal EF is explained by the preserved absolute radial wall 
thickening (due to increased end-diastolic wall thickness).
14
  Earlier studies
4,15
 that measured 
myocardial shortening instead of S reported results consistent with this assumption.  MacIver 
and Townsend
13
 verified this hypothesis using a mathematical model of LV contraction.  We 
tested the MacIver-Townsend’s hypothesis in patients with hypertension and normal EF, the 
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most common precursor condition of HFPEF. 
 
Methods 
 
The study was conducted from December 2007 to July 2012 at the 3
rd
 Department of 
Medicine, Semmelweis University, Budapest. The study complied with the Declaration of 
Helsinki, and was approved by the Institutional Committee on Human Research. All 
participants signed an informed consent. We designed to prospectively enroll 100 
hypertensive patients with normal LVEF (> 50%) and 40 normotensive, healthy controls ≥ 60 
years old over 3 years, but even during an extended period we could enroll only 94 
hypertensive patients and 18 age-matched controls.  Each patient was followed up for at least 
one year and 44 patients for 3 years (the average follow-up period was 23.3 ± 12.5 months). 
Each patient underwent a physical examination, an ECG, a detailed echocardiography, a 
carotid ultrasound and a chest X-ray at annual follow-up examinations. This study is a part of 
a multipurpose study conducted in the same patients with the objective to provide new 
insights into the pathogenesis of HFPEF by investigating its most common precursor state 
hypertension with normal EF.  We conducted 3 studies: 1) investigating the role of oxidative 
stress, inflammation, prothrombotic state and neuroendocrine activation in the pathogenesis of 
HFPEF; 2) investigating the genetic predisposition to oxidative stress, 3) The testing of 
MacIver-Townsend hypothesis. 
Eight patients quit the study, and nine patients fulfilled the exclusion criteria (HFPEF 
developed in two of them) during follow up.  Hypertension was defined by a systolic blood 
pressure >140 mmHg and/or a diastolic blood pressure >90 mmHg, or by antihypertensive 
pharmacotherapy. Blood pressure values are the average of three readings obtained using 
standard procedures. 
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Exclusion criteria included diabetes mellitus, more than a mild degree valvular or 
congenital heart disease, the presence of pacemakers or implantable cardiac defibrillators, 
prior cardiovascular surgery, coronary heart disease, prior or ongoing atrial tachyarrhythmias, 
prior or manifest heart failure, any malignant or immunological disease, anticoagulant or 
antioxidant treatment, or conditions associated with acute inflammation or stress. 
 
Standard echocardiography 
 
Echocardiography was performed using a Philips iE33 system (Philips Ultrasound, 
Bothell, WA, USA) equipped with a broadband S5-1 transducer (frequency transmitted 1.7 
MHz, received 3.4 MHz).  Cardiac dimensions and wall thicknesses were measured from two-
dimensionally guided M-mode tracings according to the recommendations of the American 
Society of Echocardiography.
16
  LV mass was computed by the Devereux-modified cube 
formula.
17
  Left atrial volume was calculated using the biplane area-length method.  The 
biplane Simpson method was applied to calculate LV end-diastolic and end-systolic volumes, 
stroke volume, and LVEF.  LV diastolic function was assessed from the combination of 
transmitral Doppler flow, pulmonary venous flow, isovolumic relaxation time (IVRT) and 
myocardial tissue Doppler septal early diastolic filling velocity (E’).  LV diastolic dysfunction 
was graded according to Nishimura and Tajik
18
: Grade 1=impaired relaxation with normal 
filling pressure, Grade 1a=impaired relaxation pattern with increased filling pressure, Grade 
2=pseudonormalized pattern, Grade 3=restrictive pattern.  Transmitral flow was acquired 
from the apical four-chamber view with the sample volume placed at the level of the tips of 
mitral leaflets.  From these traces E/A ratio, E deceleration time (DT), A wave duration and 
IVRT were determined.  Pulmonary venous flow was acquired from the same view by placing 
the sample volume within the right upper pulmonary vein.  From this trace peak systolic 
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forward flow, diastolic forward flow, atrial reversal flow duration and peak velocity were 
measured.  Radial wall thickening (radWT) was calculated using the formula: radWT = 
diastolic LV internal dimension (LVIDd) – systolic LV internal dimension (LVIDs)/2. 
 
Color tissue Doppler and speckle tracking imaging 
 
Real time color Doppler myocardial imaging was performed in the apical four-
chamber, two-chamber and five-chamber views.  Mitral annular peak systolic velocity, peak 
early diastolic filling velocity (E’), peak late diastolic (A’) and isovolumic velocity (IVV) 
were recorded from the lateral, septal, inferior, anterior, posterior, anteroseptal LV walls.  
Isovolumic acceleration (m/s
2
) was obtained by dividing IVV (cm/s) with the interval from 
the onset to the peak of IVV (ms) multiplied by 10.  The width of the image sector and the 
depth of the imaging were adjusted to achieve a frame rate more than 180/frames.  Pulse 
repetition frequency was set at the lowest possible level without aliasing.  An insonation angle 
not exceeding 20
o
 of the Doppler beam with the myocardial segment of interest was 
maintained. 
Myocardial deformation was measured using speckle tracking imaging (STI).  To 
optimize STI two-dimensional grayscale images were acquired at a frame rate of 60-80 Hz in 
the apical four-chamber, two-chamber, and three-chamber views and in the parasternal short-
axis basal and mid papillary views and three cardiac cycles were recorded.  The grayscale 
image recordings were analyzed offline using the QLAB 8.1 advanced ultrasound 
quantification software (Philips Ultrasound, Bothell, WA, USA).  The LV wall was divided 
into 17 segments and each segment was individually analyzed.  The average value of peak 
systolic longitudinal strain from the three apical views was then calculated as global LV 
longitudinal strain (GLS).  Parasternal short-axis views were obtained: 1) basal: at the tips of 
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the mitral valve leaflets, 2) mid-papillary: just below the mitral valve level.  The global 
circumferential and radial strains were calculated as the average of the respective peak 
systolic strains measured in the 6 basal and 6 mid papillary short axis view myocardial 
segments. 
 
Statistical analysis 
 
All continuous variables are expressed as mean+SD. Categorical variables are expressed as 
proportions.  One-way analysis of variance (ANOVA) was used for statistical analysis and 
comparisons among groups were performed using Tukey’s multiple comparisons test. The 
Kruskal–Wallis one-way analysis of variance was performed if Bartlett’s test indicated 
heterogeneity of variances followed by Student’s two-tailed t-test with Welch's correction. 
The level of significance was set at p<0.05.  A receiver-operating characteristic curve (ROC) 
analysis was performed to determine the most predictive variable of LV systolic dysfunction 
and the cutoff point of that variable to differentiate normal LV function and LV systolic 
dysfunction with the highest sensitivity and specificity.  Multiple linear regression analyses 
were carried out including age, gender, body mass index (BMI), LV diastolic dysfunction and 
LV mass (LVM)/body surface area (BSA) as independent variables.  Statistical analysis was 
performed using GraphPad Prism5 (GraphPad Software Inc., San Diego, CA, USA). 
 
Results 
 
Patient characteristics 
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Hypertensive patients with (HTDD+) or without LV diastolic dysfunction (HTDD-) 
and healthy controls had similar gender distribution, height, body weight, body surface area, 
diastolic blood pressure, heart rate, estimated glomerular filtration rate, hemoglobin 
concentration.  Medication was similar in the two hypertensive groups (Table 1).  There was 
no difference in age between the control and the whole hypertensive patient group (66.1+4.4 
vs. 69.4+7.7 years, the latter data are not shown in Table 1), however, patients in the HTDD+ 
group were slightly older than those in the control and HTDD- groups. The body mass index 
(BMI) was higher and the systolic blood pressure was similarly elevated in both patient 
groups vs. the control group.  The serum creatinine value was higher in the HTDD+ group 
compared with the control group (Table 1).  The heart rate measured during pulse wave 
velocity measurements (67+8/min for the control, 66+9/min for the HTDD- and 65+7/min for 
the HTDD+ groups; not shown in Table 1) was lower than that obtained during office visits 
(shown in Table 1) and showed no between-groups difference. 
   
LV diastolic dysfunction 
 
Mild, grade 1 or grade 1a LV diastolic dysfunction was present in 56/94(60%) of 
hypertensive patients and normal EF (HTDD+ group) and was absent in the remaining 40% 
(HTDD- group). 
 
LV systolic function 
 
No between-groups differences were found either in traditional LV systolic function 
indices [2D-guided M-mode EF measurement using the LVIDd
2
-LVIDs
2
/LVIDd
2 
X100 
formula, EF Simpson (EF(S)), stroke volume (SV), LV outflow tract time velocity integral 
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(LVOT-TVI), mitral annulus M-mode excursion] or in myocardial velocity measurements by 
tissue Doppler imaging (TDI) such as mitral annulus peak systolic velocity, isovolumic 
velocity (IVV) or isovolumic acceleration (IVA) (Table 2).  A trend for a decrease in SV was 
observed in the HTDD+ group. 
STI revealed LV systolic dysfunction in the hypertensive patients with normal EF.  
The absolute values of GLS were reduced in both patient groups compared with controls.  
There were no between-groups differences in circumferential and radial LV peak systolic Ss.  
The absolute values of GLS indexed to BMI (GLS/BMI) decreased in both patient groups 
versus the controls (Table 3). 
 
LA and LV volumes and LV mass 
 
No between-groups differences were found in LA volumes (Figure 1) and LV volumes 
[LV end-systolic (ESV) and end-diastolic (EDV) volumes] (Table 2).   
LVM increased in the HTDD+ group compared with the control and HTDD- groups.  
LVM/BSA increased in both patient groups versus the controls, and in the HTDD+ group 
versus the HTDD- group (Figure 1). LVM/BMI increased in the HTDD+ group versus the 
controls and a borderline increase (p=0.063) was found in the HTDD+ versus the HTDD- 
group.  EF(S) indexed to LVM or LVM and BSA (EF(S)/LVM and EF(S)/LVM/BSA), but 
not EF(S), decreased in the HTDD+ group compared with the control and HTDD- groups 
(Figure 1).  EF(S) indexed to BMI or LVM and BMI (EF(S)/BMI and EF(S)/LVM/BMI) 
decreased in both patient groups compared with the controls, and the EF(S)/LVM/BMI further 
decreased in the HTDD+ group versus the HTDD- group.  When LVM was indexed to 
height
2.7
 as recommended
19
 we obtained the same results as with indexation of LVM to BSA 
(data not shown).  The hypertensive patient group was also subdivided into subgroups without 
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LVH (HT LVH-) and with LVH (HT LVH+) according to their LVM/BSA values (LVH was 
diagnosed when LVM/BSA was >96 g/m
2
 in females and >116 g/m
2
 in males).  The HT 
LVH+ group was further subdivided into subgroups with mild (HT mild LVH: 96-108 g/m
2
 
and 116-131 g/m
2
), moderate (HT moderate LVH: 109-121 g/m
2
 and 132-148 g/m
2
) and 
severe (HT severe LVH: >122 g/m
2
 and >149 g/m
2
 for female and male patients respectively) 
LVH.  The absolute values of GLS and GLS/BMI and EF(S)/LVM/BMI decreased either 
siginificantly or showed a trend to decrease in line with the presence and the degree of LVH 
and in the HT LVH- group vs. controls (Table 4). 
In multiple logistic regression analysis involving age, gender and LV diastolic 
dysfunction as independent variables, male gender [OR (95% CI): 3.42 (1.02-11.5), p<0.05] 
and LV diastolic dysfunction [OR (95% CI): 4.29 (1.42-13.0), p<0.05] were independent 
predictors of LV systolic dysfunction as expressed by EF(S)/LVM/BMI.  In hypertensive 
patients LV diastolic dysfunction was identified as an independent predictor [OR (95% CI): 
3.26 (1.09-9.71), p<0.05] of LV systolic dysfunction as expressed by GLS/BMI. 
 
The best routine echocardiography parameter for the detection of subtle LV systolic 
dysfunction 
 
Figure 2 Panel A shows ROC curves of EF(S) indexed to LVM, BMI and/or BSA 
[EF(S)/LVM, EF(S)/BMI, EF(S)/LVM/BSA, EF(S)/LVM/BMI], which were decreased either 
in the HTDD+ group or in both patient groups compared with the controls. EF(S)/LVM/BMI 
was the best parameter to detect LV systolic dysfunction and only EF(S)/LVM/BMI 
correlated (p=0.016) with GLS.   
The ROC analysis demonstrated that GLS/BMI was a better myocardial deformation 
parameter than GLS to detect LV systolic dysfunction (Figure 2 Panel B).  The results verify 
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that EF(S)/LVM/BMI can as accurately detect subtle LV systolic dysfunction as the best LV 
systolic myocardial deformation parameter. 
 
 
Discussion 
 
Major findings 
 
Our results verified the MacIver-Townsend hypothesis in hypertensive patients with 
normal EF.  MacIver and Townsend hypothesized, using a mathematical model of LV 
contraction that preserved absolute radial wall thickening due to increased LVH and not 
increased radial or circumferential systolic function is responsible for the normal EF in 
patients with HFPEF.  Similarly to HFPEF, we verified a reduced LV systolic function in 
patients with hypertension and normal EF, the most common underlying cause and precursor 
state of HFPEF, using myocardial deformation imaging, which could not be detected by 
traditional echocardiography.  We also identified a new routine echocardiography LV systolic 
function parameter, the EF(S)/LVM/BMI, which, in contrast to EF itself, could detect subtle 
LV systolic dysfunction with the same accuracy as the more complicated and still not 
routinely applied myocardial deformation parameters.  An increased LVM in line with the 
degree of LV diastolic dysfunction, a decreased EF(S)/LVM/BMI and a trend to decrease in 
the absolute value of GLS in line with the degree of LVH and LV diastolic dysfunction seem 
to indicate that increased LVM
20
 and a subtle progressive deterioration of LV systolic 
function can develop during the transition of hypertensive heart disease to HFPEF.  In 
multiple logistic regression analysis involving age, gender and LV diastolic dysfunction as 
independent variables, male gender and LV diastolic dysfunction were found to be 
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independent predictors of LV systolic dysfunction.   
 
A possible mechanism of normal EF in HFPEF 
 
The underlying causes of HFPEF (such as hypertension, diabetes, obesity, etc.) first 
damage the most susceptible longitudinally arranged subendocardial myocardial fibers that 
will result in impaired longitudinal LV systolic function and decreased SV.  The same 
underlying diseases cause LVH due to increased oxidative stress and/or afterload, resulting in 
a decreased EDV.  EF equals to the ratio of SV/EDV.  If the EDV and SV decrease in 
parallel, the EF remains unchanged.  This possible mechanism is consistent with our results 
and the MacIver-Townsend hypothesis.   Our results show only a trend for decreased SV and 
EDV in the HTDD+ group. 
 
 
Improved clinical detection of LV systolic dysfunction in HFPEF 
 
In contrast to other authors
21
, we did not find decreased systolic mitral annular 
velocities in our hypertensive patients compared with the normal controls.  The mitral annulus 
excursion and IVV were also unchanged in the hypertensive patients. 
In contrast to the inability of EF to detect mild to moderate impairment of longitudinal 
LV systolic function, the EF(S)/LVM/BMI was decreased in our hypertensive patients. The 
ROC analysis identified EF(S)/LVM/BMI as the best routine echocardiographic parameter for 
the detection of LV systolic dysfunction. 
Although earlier human studies
2-4,15
 reported results consistent with certain elements 
of the MacIver-Townsend hypothesis, to the best of our knowledge, this is the first direct 
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testing of the hypothesis, providing a novel insight into the pathogenesis of HFPEF in 
patients.  Our results are important, because there is a growing belief that abnormalities of 
diastolic function may not be the only pathophysiological factors at play in HFPEF, and that 
the abnormalities of systole may be just as central.
22
 
Our results demonstrate that in the hypertensive patients with normal EF with or 
without mild LV diastolic dysfunction the pathological process probably involved only the 
longitudinally arranged subendocardial myofibers resulting in reduced longitudinal LV 
systolic function. The midwall myofibers responsible mainly for circumferential and radial 
deformation remained relatively preserved, resulting in normal EF.  In earlier publications 
midwall fractional shortening was a reliable indicator of LV systolic dysfunction
4-6
 and its 
prognostic value was verified
23
.  We used myocardial deformation imaging instead of midwall 
fractional shortening, because it can directly evaluate LV systolic dysfunction, while midwall 
fractional shortening is based on mathematical assumptions.  There is a significant linear 
relationship between mean circumferential S and midwall fractional shortening
,24
 and 
circumferential S has similar excellent prognostic value to midwall fractional shortening
25
. 
 
Limitations 
 
Our suggestion that, unlike EF, the application of EF(S)/LVM/BMI is a simple routine 
tool to diagnose subtle LV systolic dysfunction, should be tested in a greater number of 
patients. 
Myocardial deformation parameters are load-dependent (an increased preload 
increases, an increased afterload decreases the absolute value of myocardial S), but we did not 
measure the relation of myocardial deformation to loading conditions.  However, the 
participants were either normal controls or patients with uncomplicated hypertension without 
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or with mild LV diastolic dysfunction, and none of them had heart failure. Both increased and 
decreased preload are unlikely as only two patients had grade 1a LV diastolic dysfunction 
suggesting increased LA filling pressure, and there were no between-groups differences in 
EDV and LA volumes and in LVOT velocities and LVOT-VTI as well.  It has been 
consistently demonstrated that meridional (longitudinal) and circumferential end-systolic wall 
stresses were lower in hypertensive patients with LVH than in normal controls, indicating 
decreased afterload.  Thus, the decreased LV longitudinal and circumferential systolic 
function cannot be attributed to increased afterload in hypertensive patients with LVH.
4,5,21
  It 
was also demonstrated  that the systolic wall stress was either significantly decreased, or 
showed a trend for decrease, but was not increased in hypertensive patients without LVH
5
 or 
in a hypertensive study population in which only 25% had LVH
21
 compared with that of the 
control group.  Long axis fractional shortening was not closely related to meridional 
(longitudinal) stress
4
, suggesting that factors other than afterload have a significant influence 
on longitudinal fractional shortening.  In summary, although an important limitation of our 
study is that we did not measure myocardial deformation simultaneously with systolic wall 
stress, it seems unlikely that loading conditions significantly influenced the conclusions of 
this study. 
Another limitation of the study is that patients with intraventricular conduction 
disturbances were not excluded from the study.  However, only a small minority of 
hypertensive patients (10.5% in the HTDD- and 10.7% in the HTDD+ groups) had 
intraventricular conduction disturbance.  The STI strain results were the same after exclusion 
of these patients from the statistical analysis, therefore, we could rule out that intraventricular 
conduction disturbance in a few patients biased the results. 
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The cardiovascular event rate was very low in our relatively healthy hypertensive 
population with uncomplicated hypertension, therefore, this patient cohort was not suitable for 
the investigation of the prognostic impact of EF(S)/LVM/BMI on cardiovascular morbidity. 
Slow and incomplete inclusion of participants into the study was an additional 
limitation. 
 
Conclusions 
 
Our results verify the validity of MacIver-Townsend hypothesis, which is based on a 
mathematical model of LV contraction, in patients with hypertension and normal EF, namely 
that reduced longitudinal LV systolic function and yet normal EF is not due to a 
compensatory increase in radial and circumferential LV systolic function but to preserved 
absolute radial wall thickening caused by LVH.  Mild to moderate impairment of LV systolic 
function can be detected by EF(S)/LVM/BMI but not by EF measured by any method in these 
patients and probably in HFPEF as well.   
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Figure legends 
 
Figure 1: LV mass, left atrial volume (LAV) and EF Simpson indexed to LV mass (LVM), 
body surface area (BSA) and body mass index (BMI).  Panel A: LVM, LVM/BSA, LAV, 
LAV/BSA.  Panel B: LVM/BMI, LAV/BMI.  Panel C: EF Simpson/LVM, EF 
Simpson/LVM/BSA and EF Simpson/LVM/BMI.  * p<0.05, ** p<0.01, *** p<0.001 vs. 
control group; 
#
 p<0.05, 
##
 p<0.01, 
###
 p<0.001 vs. HTDD- group.  For further explanation see 
text. 
 
Figure 2: Receiver-operator characteristic (ROC) curves of EF Simpson and global 
longitudinal left ventricular peak systolic strain (GLS) indexed to different parameters. 
Panel A: Among EF Simpson and EF Simpson indexed to different parameters the best 
echocardiographic parameter to detect LV systolic dysfunction was EF Simpson/LVM/BMI 
with a cutoff point of <15.73 m
2
/kg
2
 (AUC: 0.804, p<0.001, sensitivity: 75.6%, specificity: 
82.4%).  The AUCs and p values of other investigated parameters were the following: 0.594, 
p=0.21 (EF Simpson); 0.726, p<0.01 (EF Simpson/LVM); 0.743, p<0.01 (EF Simpson/BMI); 
0.738, p<0.01 (EF Simpson/LVM/BSA) respectively.  Panel B: ROC curves of GLS and 
GLS/BMI demonstrating that GLS/BMI detects better LV systolic dysfunction than GLS 
(AUC: 0.79 vs. 0.73, p<0.001 vs p<0.01, sensitivity: 73.4% vs. 72.5%, specificity: 72.2% vs. 
66.7%.; the cutoff value for GLS/BMI was >-0.646 m
2
/kg for GLS was >-16.4% ).  These 
data show that EF Simpson/BMI can detect LV systolic dysfunction at least as well or even 
slightly more accurately than the better myocardial deformation parameter GLS/BMI.  
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Table 1.  Patient characteristics 
 
                                    Controls                         HTDD-                            HTDD+ 
                                      (n = 18)                          (n = 38)                          (n= 56) 
___________________________________________________________________________ 
 
Age (years)    66.1 ± 4.4   66.1 ± 5.6             71.6 ± 8.1*, ##
   
Sex (F/M)   12/6   29/9              33/23 
 
Duration of HT (years) 0   11.5 ± 11.6             14.4 ± 12.2 
 
Height (cm)             168.7 ± 8.4            164.3 ± 7.5                           164.8 ± 8.6 
 
Weight (kg)   70.1 ± 13.2  74.3 ± 18             80.2 ± 25 
 
BMI (kg/m
2
)    24.6 ± 3.7  27.6 ± 5.8*             28 ± 4**, # 
 
BSA (m
2
)      1.8 ± 0.2     1.8 ± 0.2           1.8 ± 0.3 
 
Se creatinine (μmol/L)            71.6 ±14.8             70.3 ± 14.8            82.8 ± 25.2# 
 
eGFR (mL/min)              82.6 ± 19.9             88.4 ± 26.6            75.4 ± 27.1 
 
SBP (mmHg)             129.5 ± 16.6           146.5 ± 16.2**          148.9 ± 17.9*** 
 
DBP (mmHg)    83.8 ± 9.1             85.9 ± 10.9            88.9 ± 10.8 
 
Heart rate (1/min)   71.1 ± 8.3             74.9 ± 9.3            72.2 ± 8.0 
 
Hemoglobin conc. (g/L)       140.9 ± 12.6           137.2 ± 13.1          138.9 ± 14.8 
 
Medications (number of patients) 
 
BB    1   22    30 
ACEI    0   19    35 
ARB    0   9    13  
CCB    0   15    27 
Diuretics   0   22    35 
Aldosterone antagonists   0   0    0 
Platelet inhibitors  0   14    24 
Statin    3   13    29 
PPI    2   10    8 
___________________________________________________________________________ 
*
 p<0.05, 
**
 p<0.01, 
***
 p<0.001 vs. control; 
#
 p<0.05, 
##
 p<0.01, 
### 
p<0.001 vs. HTDD- groups. 
HT=hypertension, BMI=body mass index, BSA=body surface area, eGFR=estimated glomerular filtration rate, 
SBP=systolic blood pressure, DBP=diastolic blood pressure, BB=beta-adrenergic receptor blocker, 
ACEI=angiotensin convertase enzyme inhibitor, ARB=angiotensin receptor blocker, CCB=calcium channel 
antagonist, PPI=proton pump inhibitor 
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Table 2. Traditional and myocardial tissue Doppler left ventricular function parameters 
 
Parameter                                                               Control           HTDD-           HTDD+          Significance______ 
 
_____________________________________________________________________________________________ 
EF=ejection fraction, ESV=end-systolic volume, EDV=end-diastolic volume, LV=left ventricular 
  
 
2D-guided M-mode EF (%)  65.89 ± 7.99 66.21 ± 5.96 68.66 ± 8.17               ns 
 
EF Simpson (%) 67.61 ± 5.6 66.45 ± 4.8 64.53 ± 7.03               ns 
 
Stroke volume (mL) 71.4 ± 20 68.8 ± 17.9 63.7 ± 18.8               ns 
 
ESV (mL) 34.8 ± 12.4  34.7 ±  12.0 36.9 ±  14.6               ns 
 
EDV (mL) 106.2 ± 30.2 103.6 ± 28.2   101.7 ±  27.3               ns 
 
LV outflow tract time velocity integral (cm) 23.75 ± 3.98 23.55 ± 2.91 23.55 ± 4.88               ns 
 
Mitral annulus M-mode excursion (mm) 15.3 ± 2.3 15.05 ± 2.26 15 ± 2.11               ns 
 
Mitral annulus peak systolic velocity (cm/s)  8.44 ±  1.04 7.96 ±  1.06 8.12 ±  1.4               ns 
 
Isovolumic velocity (IVV) (cm/s) 7.59 ± 1.46 6.58 ± 1.09 6.82 ± 1.82               ns 
 
Isovolumic acceleration (IVA) (m/s
2
) 1.91 ± 0.3 1.75 ± 0.27 1.83 ± 0.66               ns 
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Table 3.  Myocardial deformation parameters 
 
Parameter                                                                                                      Control                             HTDD-                           HTDD+ 
____________________________________________________________________________________________________________________ 
Global longitudinal LV peak systolic S (%)                                               -17.25+2.22                     -15.66+1.75*                   -15.35+1.88** 
Global longitudinal LV peak systolic S/BMI (m
2
/kg)                                 -0.72+0.14                        -0.59+0.14**                   -0.55+0.1*** 
The mean of the circumferential LV peak systolic S (%)                          -20.33+3.23                      -21.05+4.24                     -20.4+4.11 
The mean of the radial LV peak systolic S (%)                                           28.95+3.29                       28.48+5.87                       27.13+5.42 
Radial wall thickening (mm)                                                                         9.8+1.9                            10.0+1.9                          10.8+1.9 
____________________________________________________________________________________________________________________ 
* p<0.05, ** p<0.01, *** p<0.001 vs. the control group. 
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Table 4.  The relationship of myocardial deformation parameters and EF Simpson/LVM/BMI to LVH 
 
Parameter                                        Control          HT LVH-         HT LVH+         HT mild LVH       HT moderate LVH      HT severe LVH 
                                                             n=18               n=34                  n=60                       n=23                          n=15                           n=22 
____________________________________________________________________________________________________________________ 
GLS (%)                                           -17.25+2.22   -15.49+1.76*   -15.39+1.93**        -15.51+1.92                -15.31+1.86            -15.06+2.01* 
GLS/BMI (m
2
/kg)                              -0.72+0.14     -0.59+0.13**   -0.55+0.12***        -0.52+0.11***            -0.54+0.08**          -0.56+0.15** 
Circumferential S (%)                      -20.33+3.23   -20.92+3.95     -20.51+4.35            -19.8+3.97                  -22.37+3.81            -19.38+4.45 
Radial S (%)                                      28.95+3.29     27.48+5,34      27.96+5.92             27.3+5.68                    28.53+4.8               26.97+6.54 
EF Simpson/LVM/BMI (m
2
/kg
2
)      17.65+4.34    16.65+5.11      10.54+3.57***
,###
   12.23+3.76**
,##
          11.26+3.54**
,##
       8.7+3.72***
,###,^
 
____________________________________________________________________________________________________________________ 
GLS= Global longitudinal LV peak systolic strain, Circumferential S= The mean of the circumferential LV peak systolic strain, Radial S= The 
mean of the radial LV peak systolic strain.  * p<0.05, ** p<0.01, *** p<0.001 vs. the control group, 
#
 p<0.05, 
##
 p<0.01, 
###
 p<0.001 vs. the HT 
LVH- group, 
^
 p<0.05 vs. the HT mild LVH subgroup. 
 
 
